Development and implementation of decision-aid to improve patients' knowledge and decision-making quality for catheter-based atrial fibrillation ablation: A randomized clinical trial (IMPROVE-AF).

开发和实施决策辅助，以提高患者对基于导管的房颤消融的知识和决策质量：一项随机临床试验（IMPROVE-AF）。

• 批准号: 317633
• 负责人: Ha Andrew C
• 金额: $ 10.2万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Randomized Controlled Trials
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-10-01 至 2016-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=317633&lang=en
• 关键词: Atrial Fibrillation; Catheter Ablation For Af; Knowledge Translation; Patient Decision Aids; Quality Of Life; Randomized Clinical Trials; Shared Decision Making; Stroke Prevention

A major treatment goal for patients with atrial fibrillation (AF) is to improve their symptoms and quality of life. Catheter ablation is a useful therapy for selected patients with symptomatic AF. However, this therapy has risks, is costly, and is not suc

心房颤动（AF）患者的主要治疗目标是改善他们的症状和生活质量。对于有症状的房颤患者，导管消融是一种有效的治疗方法。然而，这种治疗有风险，费用高，而且效果不理想